Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
03/01/2000 | EP0981625A2 $i(ENTEROCOCCUS FAECALIS) POLYNUCLEOTIDES AND POLYPEPTIDES |
03/01/2000 | EP0981620A1 Hgf polypeptides and their use in therapy |
03/01/2000 | EP0981619A1 T1/st2-receptor ligand iii |
03/01/2000 | EP0981618A1 Apo-2 RECEPTOR |
03/01/2000 | EP0981617A1 Recombinant lactoferrin, methods of production from plants and uses |
03/01/2000 | EP0981616A1 Ligand polypeptide for the g protein-coupled receptor from human pituitary glands |
03/01/2000 | EP0981613A1 PARG, A GTPase ACTIVATING PROTEIN WHICH INTERACTS WITH PTPL1 |
03/01/2000 | EP0981600A1 Transformed microorganisms with improved properties |
03/01/2000 | EP0981599A2 Method for increasing yields or recombinant proteins |
03/01/2000 | EP0981548A1 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof |
03/01/2000 | EP0981547A1 Tumor-associated antigen |
03/01/2000 | EP0981544A2 Anti-bacterial methods and materials |
03/01/2000 | EP0981541A1 Psca: prostate stem cell antigen |
03/01/2000 | EP0981540A1 A NOVEL STRAIN OF $i(BACILLUS) FOR CONTROLLING PLANT DISEASES AND CORN ROOTWORM |
03/01/2000 | EP0981537A1 An infectious clone for human parainfluenza virus type 3 |
03/01/2000 | EP0981277A1 Bionematicide with efficient ovicide activity against plant-parasitic nematodes |
03/01/2000 | EP0981271A1 Compositions for the preservation of living biological materials and methods of their use |
03/01/2000 | EP0702564B1 Novel attenuated pseudomonas aeruginosa strains |
03/01/2000 | EP0666760B1 VACCINE COMPRISING PART OF CONSTANT REGION OF IgE FOR TREATMENT OF IgE-MEDIATED ALLERGIC REACTIONS |
03/01/2000 | CN1246156A Novel bacterial strains and use thereof in fermentation processes for 2-keto-L-gulonic acid production |
03/01/2000 | CN1246155A Method for production of dicarboxylic acids |
03/01/2000 | CN1246153A Mutant alpha-amylase comprising modification at residues corresponding to A210, H405 and/or T412 in Bacillus Licheniforms |
03/01/2000 | CN1246152A Esterases, DNA encoding therefor and vectors and host cells incorporating same |
03/01/2000 | CN1246151A Mutants of streptococcal toxin A and methods of use |
03/01/2000 | CN1246147A Enzymatic process for preparation of cephalosporanic 7 beta-(4-carboxybutanamide) acid by means of modified enzyme D-aminoacid oxidase of trigonopsis variabilis produced in escherichia coli |
03/01/2000 | CN1246145A Method for producing oxide with fermentation process |
03/01/2000 | CN1246144A Clostridium butyricum having preventive and therapeutic effects on hepatopathy, and liver supporting agents, foods and feeds each containing culture medium thereof |
03/01/2000 | CN1049919C Process for production of novel beer-like sparkling alcoholic beverage |
03/01/2000 | CN1049823C Biological bacteriostat and its producing method |
03/01/2000 | CN1049806C Plant stalk mycoprotein pig feeding stuff |
02/29/2000 | US6031156 Heterologous gene expression utilizing plant asparagine synthetase promoters |
02/29/2000 | US6031151 Callus-specific promoters |
02/29/2000 | US6031090 Molecular cloning of a 7TM receptor (GPR31A) |
02/29/2000 | US6031077 For prevention and treatment of heartworm infections; parasiticides; anthelmintics |
02/29/2000 | US6030835 Methods and composition for identifying group a streptococcus |
02/29/2000 | US6030834 Cdna (complementary dna) of human i kappa b kinase involved in activating transcription factors and causing inflammation; for drug screening of antiinflammatory agents |
02/29/2000 | US6030831 Tie ligand homologues |
02/29/2000 | US6030826 Human parvulin-like protein |
02/29/2000 | US6030825 Cyclophilin-type peptidyl-prolyl cis/trans isomerase |
02/29/2000 | US6030817 Transferring portion of the genome of xanthomonas campestris into a sphingomonas species enabling efficient xanthan gum production |
02/29/2000 | US6030812 Fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors |
02/29/2000 | US6030811 Polynucleotides encoding a human mystrophin clone, HSABH01 |
02/29/2000 | US6030810 Nucleotide and amino acid sequence of voltage-gated transport protein; for diagnosis and therapy of nervous system disorders; antiepileptic agents |
02/29/2000 | US6030807 Nucleic acid from the bacillus substilis l-arabinose operon for gene expression in prokaryotic hosts; inducible with exogenous l-arabinose and repressible with exogenous glucose |
02/29/2000 | US6030801 Amino acid sequence of enzyme; for screening a library for molecules which bind the polypeptide; diagnosis, treatment or prevention of cancer, immune and reproductive disorders; anticarcinogenic agents |
02/29/2000 | US6030798 Method of identifying a lipase for treatment of digestive disorders |
02/29/2000 | US6030793 Immunoassay for detecting a cell proliferation disorder using antibodies against proteins with a defined expression in prostate tissue; for diagnosis and monitoring the stage of malignancy |
02/29/2000 | US6030792 Quantitative immunoassay using capture and detection antibodies against specific amino acid sequences of collagen fragments resulting from collagenase cleavage of type ii collagen |
02/29/2000 | US6030785 Incubating a mixture containing pkr protein kinase, a viral protein containing an interferon sensitivity determining region, and an agent to be tested; then measuring the protein kinase activity where activity indicates an antiviral agent |
02/29/2000 | US6030784 Method for simultaneous identification of differentially expressed mRNAS and measurement of relative concentrations |
02/29/2000 | US6030626 Method for preparing the fimbrin protein of Haemophilus influenzae |
02/29/2000 | US6030625 Bordetella pertussis and Bordetella parapertussis strains |
02/29/2000 | US6030624 Mucosal immunogens for novel vaccines |
02/29/2000 | US6030617 Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation |
02/29/2000 | CA1340916C Method for enhancing production of secondary metabolites using clustered biosynthetic genes |
02/24/2000 | WO2000010013A2 Composition and methods for exposing antigenic epitopes on cultered microorganism |
02/24/2000 | WO2000009761A1 Improved microbial catalyst for desulfurization of fossil fuels |
02/24/2000 | WO2000009747A1 Method for separating and characterising functions potentially present in a biological sample containing nucleic acids |
02/24/2000 | WO2000009733A1 Intracellular delivery vehicles |
02/24/2000 | WO2000009732A1 Electroporation buffer with cryprotective capabilities |
02/24/2000 | WO2000009727A2 Dna shuffling to produce herbicide selective crops |
02/24/2000 | WO2000009718A1 Mass secretion/expression system of true mk family protein |
02/24/2000 | WO2000009717A1 Nucleotide and/or amino-acid sequence controlling the expression of a xylanase promoter-operator nucleotide sequence |
02/24/2000 | WO2000009716A1 Method for purifying proteins and/or biomolecule or protein complexes |
02/24/2000 | WO2000009709A2 Proteases and associated proteins |
02/24/2000 | WO2000009707A1 Cellulase producing actinomycetes, cellulase produced therefrom and method of producing same |
02/24/2000 | WO2000009705A2 Selection method |
02/24/2000 | WO2000009697A2 Pesticidal toxins and genes from bacillus laterosporus strains |
02/24/2000 | WO2000009695A2 Drug targets in candida albicans |
02/24/2000 | WO2000009693A2 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
02/24/2000 | WO2000009692A1 Novel peptides capable of modulating inflammatory heart disease |
02/24/2000 | WO2000009691A2 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
02/24/2000 | WO2000009690A1 Extracellular adhesive proteins, exadh1 and exadh2 |
02/24/2000 | WO2000009686A1 Gene |
02/24/2000 | WO2000009679A1 Method for obtaining in vitro recombined polynucleotide sequences, sequence banks and resulting sequences |
02/24/2000 | WO2000009662A1 Transgenic nonhuman mammal and uses thereof to identify compounds useful for improving long-term memory |
02/24/2000 | WO2000009661A1 Novel microorganisms and method for producing l-threonine using the same |
02/24/2000 | WO2000009660A1 Novel microorganisms and method for producing l-threonine using the same |
02/24/2000 | WO2000009658A2 Gene regulating circadian clock function and photoperiodism |
02/24/2000 | WO2000009550A1 Vanadate resistance glycosylation 4 gene |
02/24/2000 | WO2000009549A2 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
02/24/2000 | WO2000009541A1 nrdE |
02/24/2000 | WO2000009538A2 Canine growth hormone secretagogue receptor |
02/24/2000 | WO2000009534A1 Novel esk potassium channel polypeptide and polynucleotide compositions |
02/24/2000 | WO2000009157A1 Protein delivery system using human papillomavirus virus-like particles |
02/24/2000 | WO2000009154A1 Bacterial superantigen vaccines |
02/24/2000 | WO2000009148A1 Vascular endothelial growth factor 3 |
02/24/2000 | WO2000009080A1 Incorporation of exogenous lactic bacteria into the oral microflora |
02/24/2000 | WO2000008920A1 Polynucleotides controlling the expression of and coding for gene b in tomato |
02/24/2000 | WO2000003581A8 Process for preparing clavam derivatives by using polypeptides having beta-lactam synthetase activity |
02/24/2000 | WO2000001808A3 IN VIVO ADDITION OF TELOMERIC REPEATS TO EXOGENOUS DNA GENERATES EXTRACHROMOSOMAL DNAs IN THE FUNGUS $i(PESTALOTIOPSIS) |
02/24/2000 | WO1999061597A9 Expression cassette for transformation comprising a modified viral sequence driven by a suitable promoter |
02/24/2000 | WO1999060011A9 Secretion of toxins by gram-negative bacteria |
02/24/2000 | WO1999058692A3 Human apoptosis associated proteins |
02/24/2000 | WO1999058684A3 Compounds from moraxella catarrhalis |
02/24/2000 | WO1999055885A3 Novel serine protease capable of selective cleavage of insulin-like growth factor binding protein |
02/24/2000 | WO1999051722A3 Recombinant l-n-carbamoylase derived from arthrobacter aurescens, and a method for producing l-amino acids by using the same |
02/24/2000 | WO1999042586A3 Exo1 and exo2, exocytotic proteins |
02/24/2000 | DE19836382A1 Neues Tiermodell zur Entstehung und Therapie von Diabetes Mellitus New animal model for the pathogenesis and therapy of diabetes mellitus |
02/24/2000 | CA2348388A1 Gene regulating circadian clock function and photoperiodism |